Glucose Health, Inc. GLUC
0.31 USD +0.01 (+3.33%)
At closeNov 10, 2026, 4:00 PM EST
0.31 Day range 0.31
0.12 52-week range 0.674
- YTD
- +45.54%
- 1 year
- +154.10%
- Market cap
- 8.48M
- EPS (ttm)
- -0.05
- YTD return
- +45.54%
- 1-year return
- +154.10%
- Volume
- 8.50K
- Avg volume
- 14.36K
- Open
- 0.31
- Previous close
- 0.30
- Day's range
- 0.31 – 0.31
- 52-week range
- 0.12 – 0.674
- Earnings date
- Oct 24, 2022
No chart data for this range yet.
Next earnings
Oct 24, 2022
Expected Oct 24, 2022. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 8, 2024 | Sep 1, 2024 | 0.00 | -0.01 | — | — |
| Oct 24, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
| Aug 16, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| May 13, 2022 | Dec 1, 2021 | 0.00 | — | — | — |
| Nov 3, 2021 | Sep 1, 2021 | 0.00 | -0.01 | — | — |
| Aug 9, 2021 | Jun 1, 2021 | 0.00 | 0.00 | — | — |
News
Glucose Health (OTCMKTS:GLUC) Shares Down 22.7% – Should You Sell? 
Glucose Health, Inc. (GLUC) Reports Surge in GlucoDown Sales Among two of the Largest Retailers in the National Drug Store Channel 
Glucose Health, Inc. (GLUC) Appoints Gerry David as Chairman of Strategic Advisory Board of Directors 
Critical Survey: Glucose Health (OTCMKTS:GLUC) versus GE HealthCare Technologies (NASDAQ:GEHC) 
Financial Survey: Glucose Health (OTCMKTS:GLUC) versus EssilorLuxottica (OTCMKTS:ESLOY) 
Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign 
Financial Contrast: Glucose Health (OTCMKTS:GLUC) vs. Abbott Laboratories (NYSE:ABT) 
High Tide (NASDAQ:HITI) vs. Glucose Health (OTCMKTS:GLUC) Critical Review 
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand 
Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy
Your note
Sign in to keep a note on GLUC — it syncs with the Stock Master app.